119 related articles for article (PubMed ID: 468721)
1. Biological activity of macromomycin.
Hidaka T; Yano Y; Yamashita T; Watanabe K
J Antibiot (Tokyo); 1979 Apr; 32(4):340-6. PubMed ID: 468721
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor activity of macromomycin].
Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
[TBL] [Abstract][Full Text] [Related]
3. Studies on auromomycin.
Yamashita T; Naoi N; Hidaka T; Watanabe K; Kumada Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1979 Apr; 32(4):330-9. PubMed ID: 468720
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
[TBL] [Abstract][Full Text] [Related]
5. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
[TBL] [Abstract][Full Text] [Related]
6. Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity.
Morimoto M; Okubo S; Tomita F; Marumo H
J Antibiot (Tokyo); 1981 Jun; 34(6):701-7. PubMed ID: 6792176
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of a new antibiotic, neothramycin.
Hisamatsu T; Uchida S; Takeuchi T; Ishizuka M; Umezawa H
Gan; 1980 Jun; 71(3):308-12. PubMed ID: 7418976
[TBL] [Abstract][Full Text] [Related]
9. Purification and mechanism of action of macromomycin.
Sawyer TH; Prestayko AW; Crooke ST
Cancer Res; 1979 Apr; 39(4):1180-4. PubMed ID: 421201
[TBL] [Abstract][Full Text] [Related]
10. The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity.
Jackson RC; Fry DW; Boritzki TJ; Roberts BJ; Hook KE; Leopold WR
Adv Enzyme Regul; 1985; 23():193-215. PubMed ID: 3840949
[TBL] [Abstract][Full Text] [Related]
11. Studies on the antitumor activity of an alazopeptin isolated from a new strain of Streptomyces.
Hata T; Umezawa I; Iwai Y; Katagiri M; Awaya J
J Antibiot (Tokyo); 1973 Mar; 26(3):181-3. PubMed ID: 4205875
[No Abstract] [Full Text] [Related]
12. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
Matsushita Y; Kumagai H; Yoshimoto A; Tone H; Ishikura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
[TBL] [Abstract][Full Text] [Related]
13. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Holm B; Jensen PB; Sehested M
Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
15. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C.
Arai T; Takahashi K; Ishiguro K; Mikami Y
Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625
[TBL] [Abstract][Full Text] [Related]
16. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I.
Ono Y; Kozai Y; Ootsu K
Gan; 1982 Dec; 73(6):938-44. PubMed ID: 6186564
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
19. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
20. Studies on antineoplastic activity of naphthomycin, a naphthalenic ansamycin, and its mode of action.
Okabe T; Yuan BD; Isono F; Sato I; Fukazawa H; Nishimura T; Tanaka N
J Antibiot (Tokyo); 1985 Feb; 38(2):230-5. PubMed ID: 3997667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
